Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug 23;16(1):675.
doi: 10.1186/s12885-016-2727-x.

Outcomes of uterine sarcoma found incidentally after uterus-preserving surgery for presumed benign disease

Jung-Yun Lee  1 , Hyun Soo Kim  2 , Eun Ji Nam  1 , Sang Wun Kim  1 , Sunghoon Kim  1 , Young Tae Kim  3
Affiliations

Outcomes of uterine sarcoma found incidentally after uterus-preserving surgery for presumed benign disease

Jung-Yun Lee et al. BMC Cancer. .

Abstract

Background: The aims of this study were to evaluate the impact of initial uterus-preserving surgery, such as myomectomy or subtotal hysterectomy, on the recurrence rates of patients with uterine sarcoma found incidentally and to investigate the role of surgical re-exploration in this disease subset.

Methods: We performed a retrospective chart review for patients who had previously undergone either total hysterectomy or subtotal hysterectomy or myomectomy at the time of initial surgery for presumed benign uterine leiomyoma and were found to have uterine sarcoma on final pathology. Survival analysis was performed comparing patients according to the type of initial surgery.

Results: Between 2006 and 2014, 45 patients with uterine sarcoma were identified. Myomectomy or subtotal hysterectomy was performed in 15 patients, and 30 patients underwent total hysterectomy as the initial surgery. Of the patients who underwent myomectomy or subtotal hysterectomy as the initial surgery (n = 15), 14 were re-explored to complete staging. Of the patients who underwent re-exploration (n = 14), five (35.8 %) had remnant sarcoma on the remaining uterus and no patients had disseminated disease. A Kaplan-Meier curve and log-rank test showed no difference in progression-free survival (P = 0.941) between the two groups.

Conclusion: Initial uterus-preserving surgery does not appear to be associated with an adverse impact on survival outcomes for unexpected uterine sarcoma when surgical re-exploration was performed immediately. As such, surgical re-exploration may be useful for removing any remnant sarcoma.

Keywords: Endometrial stromal sarcoma; Leiomyosarcoma; Morcellation; Myomectomy; Survival analysis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow diagram in patients with incidentally found uterine sarcoma
Fig. 2
Fig. 2
Progression-free survival of patients with unexpected sarcoma stratified by type of initial surgery (myomectomy/subtotal hysterectomy vs. total hysterectomy)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Stein K, Ascher-Walsh C. A comprehensive approach to the treatment of uterine leiomyomata. Mt Sinai J Med. 2009;76:546–556. doi: 10.1002/msj.20145. - DOI - PubMed
    1. Borah BJ, Nicholson WK, Bradley L, Stewart EA. The impact of uterine leiomyomas: a national survey of affected women. Am J Obstet Gynecol. 2013;209:319. doi: 10.1016/j.ajog.2013.07.017. - DOI - PMC - PubMed
    1. Food and Drug Administration. Quantitative assessment of the prevalence of unsuspected uterine sarcoma in women undergoing treatment of uterine fibroids. Summary and key findings. 2014. http://www.fda.gov/downloads/medicaldevices/safety/alertsandnotices/ucm3.... Accessed 17 Apr 2015.
    1. Cusido M, Fargas F, Baulies S, Plana A, Rodriguez I, Tresserra F, et al. Impact of surgery on the evolution of uterine sarcomas. J Minim Invasive Gynecol. 2015;22:1068–1074. doi: 10.1016/j.jmig.2015.05.024. - DOI - PubMed
    1. Zhang J, Zhang J, Dai Y, Zhu L, Lang J, Leng J. Clinical characteristics and management experience of unexpected uterine sarcoma after myomectomy. Int J Gynaecol Obstet. 2015;130:195–199. doi: 10.1016/j.ijgo.2015.01.009. - DOI - PubMed